MIRION TECHNOLOGIES INC
MIRNYSETrading Snapshot
- Day Range
- $14.45 β $16.78
- 52-Week Range
- $14.04 β $30.28
- Volume (shares)
- 10,994,502
- Avg Volume (shares)
- β
- Shares Outstanding
- 249.0M
- Next Earnings
- 2027-02-08
Fundamentals Snapshot
- Annual Revenue
- $925M
- Last Q Revenue
- $267M
- P/E Ratio
- 156.6
- P/S Ratio
- 3.7x
- EPS (TTM)
- $0.09
- Dividend Yield
- β
- Dilution (1yr)
- +27.4%
MIRION TECHNOLOGIES INC
MIRAbout MIRION TECHNOLOGIES INC
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Mirion Technologies, Inc. (MIR) Q3 2026 Earnings Call Transcript
Mirion Technologies, Inc. ( MIR ) Q3 2026 Earnings Call October 28, 2026 10:00 AM EDT Company Participants Eric Linn - Vice President of Investor Relations Thomas Logan - Founder, Medical Group President, CEO & Chairman

What Mirion Technologies (MIR) Said on Its Q3 Earnings Call
Mirion Technologies NYSE: MIR reported third-quarter revenue growth of 24.5% and sharply higher orders, citing accelerating demand from nuclear power customers and growing backlog conversion. The company also raised its

Mirion Technologies (MIR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Mirion Technologies (MIR) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and

Mirion Technologies, Inc. (MIR) Matches Q3 Earnings Estimates
Mirion Technologies, Inc. (MIR) came out with quarterly earnings of $0.12 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.12 per share a year ago.

Mirion Announces Third Quarter 2026 Financial Results
ATLANTA--(BUSINESS WIRE)--Mirion (βweβ or the βcompanyβ) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets,

Mirion Extends Support of IAEA Mission to Advance Cancer Care Globally through Rays of Hope Donation
ATLANTA--(BUSINESS WIRE)--Mirion, a leading provider of advanced radiation safety solutions, has announced support for the International Atomic Energy Agency (IAEA) Rays of Hope initiative, which aims to help address dis